208 related articles for article (PubMed ID: 11521435)
1. [Comparative study of the role of cytokines in various eye diseases. 2. Diabetic retinopathy].
Slepova OS; Gerasimenko VL; Zakharova GIu; Novikova-Bilak TI
Vestn Oftalmol; 2001; 117(3):35-7. PubMed ID: 11521435
[TBL] [Abstract][Full Text] [Related]
2. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
Adamiec J; Oficjalska-Młyńczak J
Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
[TBL] [Abstract][Full Text] [Related]
3. [Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].
Wilczyński M; Dzivgielewski K
Klin Oczna; 2006; 108(1-3):66-9. PubMed ID: 16883944
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study of the role of cytokines in different forms of eye diseases. 1. Tumor necrosis factor-alpha].
Slepova OS; Gerasimenko VA; Makarov VP; Kushnir VN; Zakharova GIu; Bykovskaia GN; Vartanian IR; Sadrislamova LF
Vestn Oftalmol; 1998; 114(3):28-32. PubMed ID: 9720396
[TBL] [Abstract][Full Text] [Related]
5. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy.
Demircan N; Safran BG; Soylu M; Ozcan AA; Sizmaz S
Eye (Lond); 2006 Dec; 20(12):1366-9. PubMed ID: 16284605
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological approach to diabetic retinopathy.
De La Cruz JP; González-Correa JA; Guerrero A; de la Cuesta FS
Diabetes Metab Res Rev; 2004; 20(2):91-113. PubMed ID: 15037985
[TBL] [Abstract][Full Text] [Related]
7. Management of proliferative diabetic retinopathy.
Gündüz K; Bakri SJ
Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
[TBL] [Abstract][Full Text] [Related]
8. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.
Gustavsson C; Agardh E; Bengtsson B; Agardh CD
J Diabetes Complications; 2008; 22(5):309-16. PubMed ID: 18413212
[TBL] [Abstract][Full Text] [Related]
9. Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy.
Sánchez MC; Luna JD; Barcelona PF; Gramajo AL; Juarez PC; Riera CM; Chiabrando GA
Exp Eye Res; 2007 Nov; 85(5):644-50. PubMed ID: 17826767
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
Hernández C; Segura RM; Fonollosa A; Carrasco E; Francisco G; Simó R
Diabet Med; 2005 Jun; 22(6):719-22. PubMed ID: 15910622
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary results of laser coagulation of the retina in the treatment of diabetic retinopathy in pregnant women].
Mirkiewicz-Sieradzka B; Romanowska B; Kalita J; Sieradzki J
Klin Oczna; 1992; 94(5-6):147-8. PubMed ID: 1453676
[TBL] [Abstract][Full Text] [Related]
12. Improved retinal capillary perfusion following treatment of severe proliferative diabetic retinopathy.
Scott IU; Amirikia A; Flynn HW
Ophthalmic Surg Lasers; 2000; 31(2):148-50. PubMed ID: 10743928
[TBL] [Abstract][Full Text] [Related]
13. Visual prognosis after panretinal photocoagulation for proliferative diabetic retinopathy.
Bek T; Erlandsen M
Acta Ophthalmol Scand; 2006 Feb; 84(1):16-20. PubMed ID: 16445434
[TBL] [Abstract][Full Text] [Related]
14. [The adaptometry study in patients with diabetic retinopathy].
Iliuşi FG; Preda M
Oftalmologia; 2004; 48(1):43-7. PubMed ID: 15279418
[TBL] [Abstract][Full Text] [Related]
15. The role of vascular endothelial growth factor, tumor necrosis factor alpha and interleukin-6 in pathogenesis of diabetic retinopathy.
Myśliwiec M; Balcerska A; Zorena K; Myśliwska J; Lipowski P; Raczyńska K
Diabetes Res Clin Pract; 2008 Jan; 79(1):141-6. PubMed ID: 17716775
[TBL] [Abstract][Full Text] [Related]
16. Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy.
Patel JI; Saleh GM; Hykin PG; Gregor ZJ; Cree IA
Eye (Lond); 2008 Feb; 22(2):223-8. PubMed ID: 17001327
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
[TBL] [Abstract][Full Text] [Related]
18. [The influence of retinal argon laser photocoagulation on results of vitreous fluorophotometry in patients with diabetic retinopathy].
Gierek-Lapińska A; Formińska-Kapuścik M; Janiec S; Rzendkowski M
Klin Oczna; 1994; 96(8-9):263-4. PubMed ID: 7897990
[TBL] [Abstract][Full Text] [Related]
19. Management of eye disease in the insulin-dependent diabetic patient.
Klein R
Prim Care; 1983 Dec; 10(4):677-90. PubMed ID: 6562666
[TBL] [Abstract][Full Text] [Related]
20. [Effect of argon laser photocoagulation on diabetic retinopathy].
Wei ZY; Hu SX; Tang N; Wu J; Wang J
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1313-5. PubMed ID: 15567792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
